Cargando...
High-dose Somatostatin Analogues for Progressive Neuroendocrine Tumours
Neuroendocrine tumours are a heterogeneous group of neoplasms with a variety of treatment options, but studies suggest they should in most cases, if they are not curable surgically, be treated initially with monthly long-acting somatostatin analogues. New data recently published suggest that if pati...
Gardado en:
| Publicado en: | Eur Endocrinol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Touch Medical Media
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7572164/ https://ncbi.nlm.nih.gov/pubmed/33117438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17925/EE.2020.16.2.93 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|